Evaluating Functional Equivalency as a Lyophilization Cycle Transfer Tool - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Evaluating Functional Equivalency as a Lyophilization Cycle Transfer Tool
The authors describe a comprehensive methodology for establishing functional equivalence among various lyophilizers.


Pharmaceutical Technology
Volume 33, Issue 9, pp. 54-70

Rationale of methodology

Comparability of relevant technical characteristics of the lyophilizer units. As long as the critical process parameters such as shelf temperature, chamber pressure, condenser temperature, and duration of various cycle steps are held within a specified range, the drying profile as well as the quality of the final product will remain consistent from batch-to-batch, irrespective of the lyophilizer unit used. The majority of commercial lyophilization cycles in use today are very conservative with respect to equipment capacity. That is, the maximum operating capacities of various systems such as refrigeration, vacuum system, shelf-temperature control, load of water to be sublimed versus condenser capacity, and so forth are not challenged during the course of routine production cycles. This fact enhances the reliability of production and allows for a successful cycle transfer between apparently dissimilar units. In such case, as long as the selected cycle parameters are within the performance envelope of a given lyophilizer, the cycle can be reliably executed within narrow process limits. However, in some instances, not only good control of the lyophilization parameters (including the chamber pressure, shelf temperature, duration, and so forth) are necessary for scale up, but also there must be comparability of the lyophilizer unit dependent factors such as shelf area, finish of the shelf material (e.g., thickness of the shelf wall), and the heat-transfer rate (e.g., ice sublimation rate in primary drying).

There are, however, several equipment characteristics that may have a pronounced effect upon the course of the typical lyophilization cycle. These characteristics include the type of vacuum instrumentation (e.g., capacitance manometer or thermocouple gauge), method of pressure control (e.g., bleed gas or vacuum valve stifling), shelf-temperature uniformity, and range of shelf-temperature thermo regulation. These technical characteristics are easily evaluated by surveying the equipment and equipment specifications and reviewing data generated during the initial and subsequent routine qualifications (11). The authors reviewed selected technical characteristics of three production-scale lyophilizers (labeled A420FT, B420FT, and C220FT).

Comparison of sublimation rate studies using mannitol solution. Each of the three consecutive stages in lyophilization cycle (i.e., freezing, primary drying, and secondary drying) must be fully executed to yield a dry product with consistently low residual moisture. Although the final moisture level throughout the lot reaches a constant low value at the end of terminal drying, the drying rates of individual vials during earlier stages of the cycle may be different in the load such that some vials may dry faster than others. As the drying progresses, the remaining vials eventually catch up and the entire lot is fully dry and attains a low uniform residual moisture level after a sufficiently long period of drying. Such intermediate non-uniformity of drying rate generally occurs because of vial-related factors (e.g., differences in vials, freezing-time differences, location of vials, variability in stopper placement) or equipment-related factors (e.g., shelf temperature gradients during temperature ramps, radiant heat from the chamber walls and door).

In experiments performed in the laboratory using a pilot-scale lyophilizer (25 ft2, 40-L condenser capacity), the drying rate profiles during the early part of sublimation (primary drying) were within ±10% of each other in three separate but identical runs. The runs were performed using trays of vials filled with 62-mL mannitol solutions in 100-cm3 glass vials.

Because a given lyophilizer unit is, by definition, functionally equivalent to itself, application of this same limit to a comparison of drying rates between different lyophilizer units provides a rational approach for functional equivalence. Thus, the limit of ±10% variability within different units was selected as the acceptance criteria for functional equivalence.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What is the single greatest threat to maintaining manufacturing processes at your facility?
Quality issues
Facility/environment problems
Process development problems
Production equipment downtime
Raw material supply problems
Regulatory restrictions
Business decisions to limit production
Quality issues
67%
Facility/environment problems
0%
Process development problems
0%
Production equipment downtime
0%
Raw material supply problems
33%
Regulatory restrictions
0%
Business decisions to limit production
0%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Patent Settlements Become More Risky
Praise and Perils for Biotechnology Patent Policy
Risk-Mitigation Strategies in Drug Manufacturing for Emerging Markets
Quality Focus: Ensuring Raw Material Transparency
Advertising of Prescription Drugs  Keeping it Honest and Balanced
Source: Pharmaceutical Technology,
Click here